doi: 10.1016/s0140-6736(89)90452-2.
Complement receptors: another port of entry for HIV
- PMID: 2569072
- DOI: 10.1016/s0140-6736(89)90452-2
Item in Clipboard
Complement receptors: another port of entry for HIV
Lancet.
.
No abstract available
Similar articles
-
Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion.J Exp Med. 1991 May 1;173(5):1151-8. doi: 10.1084/jem.173.5.1151. J Exp Med. 1991. PMID: 1827139 Free PMC article.
-
AIDS. Do antibodies enhance the infection of cells by HIV?Nature. 1989 Aug 10;340(6233):431-2. doi: 10.1038/340431a0. Nature. 1989. PMID: 2787895 Free PMC article. No abstract available.
-
Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysis.AIDS Res Hum Retroviruses. 1994 Jul;10(7):829-37. doi: 10.1089/aid.1994.10.829. AIDS Res Hum Retroviruses. 1994. PMID: 7527236
-
Interaction of complement with HIV-1 and Candida albicans: molecular mechanisms and biological implications.Mol Immunol. 1990 Dec;27(12):1349-53. doi: 10.1016/0161-5890(90)90042-x. Mol Immunol. 1990. PMID: 2274064 Review. No abstract available.
-
[The pathogenic concepts in the acquired immunodeficiency syndrome].Bacteriol Virusol Parazitol Epidemiol. 1992 Jan-Jun;37(1-2):39-52. Bacteriol Virusol Parazitol Epidemiol. 1992. PMID: 1472779 Review. Romanian. No abstract available.
Cited by
-
Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion.J Exp Med. 1991 May 1;173(5):1151-8. doi: 10.1084/jem.173.5.1151. J Exp Med. 1991. PMID: 1827139 Free PMC article.
-
Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.Infect Immun. 1992 Mar;60(3):721-7. doi: 10.1128/iai.60.3.721-727.1992. Infect Immun. 1992. PMID: 1541544 Free PMC article. Review. No abstract available.
-
Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.Springer Semin Immunopathol. 1997;18(3):371-90. doi: 10.1007/BF00813504. Springer Semin Immunopathol. 1997. PMID: 9089955 Review. No abstract available.
-
Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line.J Virol. 1991 Jan;65(1):541-5. doi: 10.1128/JVI.65.1.541-545.1991. J Virol. 1991. PMID: 1845908 Free PMC article.
-
Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55).J Exp Med. 1996 Jan 1;183(1):307-10. doi: 10.1084/jem.183.1.307. J Exp Med. 1996. PMID: 8551237 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
